Menten AI

Menten AI is a company that develops a physics-based generative AI platform called MAUD 1.0 for peptide macrocycle drug design. The platform is validated across the preclinical discovery pipeline and is trusted by top-10 pharma partners. Menten AI is backed by leading VCs.

Menten AI is an American biotech quantum computing company. It is pioneering generative AI to design cyclic peptide therapeutics. Its proprietary platform, MAUD 1.0, integrates generative AI, physics-based modeling, and quantum chemistry simulations to design novel peptide macrocycles from scratch. The platform has been validated across the preclinical pipeline, demonstrating nM-level potency, membrane permeability, favorable DMPK properties, and in vivo efficacy. Menten AI partners with top-10 pharma leaders such as Bristol Myers Squibb and is backed by investors including Social Impact Capital, Uncork Capital, Khosla Ventures, and Y Combinator.

• MAUD 1.0

1. Menten AI
2. About Us - Menten AI
3. Menten AI